1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals Hosts Business Update Conference Call
December 10, 2020 08:30 ET | Timber Pharmaceuticals
Call to be held on Thursday, December 17th at 11:00am EST WOODCLIFF LAKE, N.J., Dec. 10, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE...
1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals to Present at the 13th Annual LD Micro Main Event Conference
December 08, 2020 16:05 ET | Timber Pharmaceuticals
Presentation on Tuesday December 15th  at 10:40am EST LOS ANGELES, CA, Dec. 08, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American:...
1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals Signs Waiver Agreement with Warrant Holders
November 20, 2020 09:05 ET | Timber Pharmaceuticals
WOODCLIFF LAKE, NJ, Nov. 20, 2020 (GLOBE NEWSWIRE) -- NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the...
1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2020 Financial Results
November 12, 2020 16:53 ET | Timber Pharmaceuticals
WOODCLIFF LAKE, NJ, Nov. 12, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the...
1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for BPX-01 and BPX-04
September 15, 2020 08:00 ET | Timber Pharmaceuticals
- Formal notice confirms intent to grant patent for pharmaceutical tetracycline compositions for dermatological use - WOODCLIFF LAKE, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --...
1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference
September 11, 2020 16:29 ET | Timber Pharmaceuticals
Virtual Presentation on Wednesday, September 16th at 12:30 PM ET WOODCLIFF LAKE, NJ, Sept. 11, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire-- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”)...
1589917612572_5ec429193ef97e0004f1060c_logo.png
imber Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference
September 11, 2020 16:05 ET | Timber Pharmaceuticals
Virtual Presentation on Wednesday, September 16th at 12:30 PM ET WOODCLIFF LAKE, NJ, Sept. 11, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”)...
1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals Announces Appointment of Dr. David Cohen and Dr. Lubor Gaal to Board of Directors
August 19, 2020 16:10 ET | Timber Pharmaceuticals
WOODCLIFF LAKE, NJ, Aug. 19, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the...
1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals Provides Business Update and Announces Second Quarter 2020 Financial Results 
August 18, 2020 16:10 ET | Timber Pharmaceuticals
Phase 2b Clinical Trials for Each of the Company’s Lead Assets in Orphan Dermatologic Diseases are Progressing as Planned WOODCLIFF LAKE, NJ, Aug. 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --...
1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals Announces European Patent Office Intends to Grant Patent for BPX-01 and BPX-04
July 22, 2020 08:00 ET | Timber Pharmaceuticals
 Stable topical composition has potential to reduce side effects of orally delivered compositions in treatment of acne and rosacea  WOODCLIFF LAKE, NJ, July 22, 2020 (GLOBE NEWSWIRE) -- via...